Photo of Desiree Azizoddin,  Psy.D.

Desiree Azizoddin, Psy.D.

Dana-Farber Cancer Institute

Dana-Farber Cancer Institute
Phone: (617) 632-2574


Desiree_azizoddin@dfci.harvard.edu

Photo of Desiree Azizoddin,  Psy.D.

Dana-Farber Cancer Institute
Phone: (617) 632-2574


Desiree_azizoddin@dfci.harvard.edu

Visualize Collaborations

Desiree Azizoddin, Psy.D.

Dana-Farber Cancer Institute

EDUCATIONAL TITLES

  • Assistant Professor, Psychiatry, Harvard Medical School
  • Assistant Professor, Supportive Oncology, Dana-Farber Cancer Institute

HCC PROGRAM AFFILIATION

Research Abstract

N/A

Publications from Harvard Catalyst Profiles

Powered by Harvard Catalyst
  • Azizoddin DR, Zhao J, DeForge SM, Chen M, Nipp R, Stagg JH, Bond K, Leckie R, Hilton BT, Neil JM, Tulsky JA, Pirl W, Edwards RR, Darnall BD. Initial Feasibility and Acceptability of Cancer Pain 101: An Interdisciplinary, Single-Session, Telehealth Intervention for Patients With Cancer-Related Pain. Cancer Med 2025; 14:e70898. PubMed
  • Azizoddin DR, DeForge SM, Edwards RR, Baltazar AR, Schreiber KL, Allsop M, Banson J, Oseuguera G, Businelle M, Tulsky JA, Enzinger AC. Serious Games for Serious Pain: Development and Initial Testing of a Cognitive Behavioral Therapy Game for Patients With Advanced Cancer Pain. JCO Clin Cancer Inform 2024; 8:e2400111. PubMed
  • DeForge SM, Smith K, Anderson KA, Baltazar AR, Beck M, Enzinger AC, Tulsky JA, Allsop M, Edwards RR, Schreiber KL, Azizoddin DR. Pain coping, multidisciplinary care, and mHealth: Patients' views on managing advanced cancer pain. 2024; 33:e6308. PubMed
  • Azizoddin DR, DeForge SM, Baltazar A, Edwards RR, Allsop M, Tulsky JA, Businelle MS, Schreiber KL, Enzinger AC. Development and pre-pilot testing of STAMP + CBT: an mHealth app combining pain cognitive behavioral therapy and opioid support for patients with advanced cancer and pain. Support Care Cancer 2024; 32:123. PubMed
  • Azizoddin DR, Wilson JM, Flowers KM, Beck M, Chai P, Enzinger AC, Edwards R, Miaskowski C, Tulsky JA, Schreiber KL. Daily pain and opioid administration in hospitalized patients with cancer: the importance of psychological factors, recent surgery, and current opioid use. Pain 2023. PubMed
  • Azizoddin DR, Schreiber K, Beck MR, Enzinger AC, Hruschak V, Darnall BD, Edwards RR, Allsop MJ, Tulsky JA, Boyer E, Mackey S. Chronic pain severity, impact, and opioid use among patients with cancer: An analysis of biopsychosocial factors using the CHOIR learning health care system. Cancer 2021. PubMed
  • Azizoddin DR, Knoerl R, Adam R, Kessler D, Tulsky JA, Edwards RR, Enzinger AC. Cancer pain self-management in the context of a national opioid epidemic: Experiences of patients with advanced cancer using opioids. Cancer 2021. PubMed
  • Azizoddin DR, Adam R, Kessler D, Wright AA, Kematick B, Sullivan C, Zhang H, Hassett MJ, Cooley ME, Ehrlich O, Enzinger AC. Leveraging mobile health technology and research methodology to optimize patient education and self-management support for advanced cancer pain. Support Care Cancer 2021. PubMed
  • Schreiber KL, Zinboonyahgoon N, Flowers KM, Hruschak V, Fields KG, Patton ME, Schwartz E, Azizoddin D, Soens M, King T, Partridge A, Pusic A, Golshan M, Edwards RR. Prediction of Persistent Pain Severity and Impact 12 Months After Breast Surgery Using Comprehensive Preoperative Assessment of Biopsychosocial Pain Modulators. Ann Surg Oncol 2021. PubMed
  • Azizoddin DR, Enzinger AC, Wright AA, Yusufov M, Tulsky JA, Campbell EG, Bolcic-Jankovic D, Nayak MM, Braun IM. Oncologists' perspectives on medical marijuana use by older adults. 2020. PubMed
  • Azizoddin DR, Lakin JR, Hauser J, Rynar LZ, Weldon C, Molokie R, Enzinger AC, Payvar S, Martin JL. Meeting the guidelines: Implementing a distress screening intervention for veterans with cancer. 2020; 29:2067-2074. PubMed